• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM CA 15-3 (CA 15-3); SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM CA 15-3 (CA 15-3); SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR Back to Search Results
Model Number N/A
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/12/2022
Event Type  malfunction  
Event Description
The customer reports observation of an elevated atellica im ca 15-3 result which was discordant relative to patient history.The customer obtained an elevated atellica im ca 15-3 result for a 33-year-old female patient which was considered inconsistent with patient history, and not reported to the physician.The result was considered falsely elevated, as the same patient sample had previously produced a lower result when tested earlier using the same method.There are no allegations of patient harm, changes in treatment, or delays of diagnosis in association with the observed result discordance.
 
Manufacturer Narrative
A customer from outside the united states reports observation of an elevated atellica im ca 15-3 result for a 33-year-old female patient which was considered discordant relative to a lower result obtained earlier.The sample was originally tested on 2022-10-29 and was re-tested on 2022-11-05 as part of a retrospective review of test results following a quality control (qc) failure observation (high results) on 2022-11-10.It is noted that different calibrator lots had been used for the two tests.No qc excursions were reported in assocation with the discordant observation.The assay's instructions for use (ifu) advises the following, under limitations: "measurements of ca 15-3 should always be used in conjunction with other diagnostic procedures, including information from the patient's clinical evaluation." siemens is investigating.
 
Manufacturer Narrative
Mdr 1219913-2022-00408 was initially filed on 2022-11-30.Additional information, 2022-12-29: siemens has concluded the investigation.A customer from outside the united states reported observation of an elevated atellica im ca 15-3 result which was inconsistent with patient history following a change to a new ca 15-3 calibrator.Review of quality control (qc) data showed a similar shift in results.The observed issue was resolved locally by recalibration of the assay.Siemens' review of customer data showed changes in assay signal level indicative of an issue with the customer's ca 15-3 reagents.It was noted that the storage refrigerator has an internal light, which may represent a cause for reagent degradation.The customer was appropriately advised.A review of internal data indicates that atellica im ca 15-3 kit lot 204 and calibrator lot c4370 were performing as intended.The cause of the discordant result could not be definitively identified, but reagent handling cannot be ruled out as a potential cause.Based on the investigation, no product problem was identified.The customer is operational, and no further support is needed.Note: in section h6, the codes for investigation findings and investigation conclusion have been updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM CA 15-3 (CA 15-3)
Type of Device
SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
333 coney street
east walpole MA 02032
Manufacturer Contact
barry
333 coney street
east walpole, MA 02032
5082985306
MDR Report Key15890941
MDR Text Key307687537
Report Number1219913-2022-00408
Device Sequence Number1
Product Code MOI
UDI-Device Identifier00630414598130
UDI-Public00630414598130
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K012357
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/18/2023
Device Model NumberN/A
Device Catalogue Number10995486
Device Lot Number204
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/16/2022
Initial Date FDA Received11/30/2022
Supplement Dates Manufacturer Received12/29/2022
Supplement Dates FDA Received01/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/18/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age33 YR
Patient SexFemale
-
-